Undisclosed HDP Programs

About Riptide Bioscience

Founded in 2012 and based in Vallejo, California, Riptide Bioscience is a private, preclinical-stage biotech focused on a platform of engineered Host Defense Peptides (HDPs). The company designs synthetic peptides with significantly enhanced efficacy over natural versions to address infection and dysregulated inflammation. Riptide has advanced its research through collaborations with academic institutions and non-dilutive funding from U.S. government agencies, positioning itself for potential pharmaceutical partnerships to develop its proprietary drug candidates.

Therapeutic Areas